Patent details
300907
Product Name:
Deoxycholinezuur natriumzout
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300907
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1758590
Status:
Withdrawn
Application number:
300907
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
RVG120593
Marketing Authorization Type:
EEA
Marketing Authorization Date:
04/08/2017
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
03/11/2017
First Marketing Authorization date:
04/08/2017
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
07/11/2017
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
14/12/2023
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
19/12/2022
Name:
The Regents of the University of California
Address:
1111 Franklin Street 12th Floor, OAKLAND, CA 94607-5200, United States of America (US)
From:
19/12/2022
Name:
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Address:
1124 West Carson Street, 90250-2064, TORRANCE, CA, United States of America (US)
Historical Applicant/holder
From:
03/11/2017
To:
19/12/2022
Name:
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Address:
1124 West Carson Street, TORRANCE, CA 90250-2064, United States of America (US)
From:
03/11/2017
To:
19/12/2022
Name:
The Regents of the University of California
Address:
1111 Franklin Street 12th Floor, OAKLAND, CA 94607-5200, United States of America (US)
Agent
Name:
ir. A. Blokland c.s.
From:
03/11/2017
Address:
Algemeen Octrooi- en Merkenbureau B.V.
Postbus 645, 5600 AP, Eindhoven, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
51/23
Publication date:
20/12/2023
Description:
Lapse or annulment
2
Bulletin Heading:
CO
Journal edition number:
52/22
Publication date:
28/12/2022
Description:
Changes in the Netherlands Patent Register
3
Bulletin Heading:
SPC
Journal edition number:
45/17
Publication date:
08/11/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202203090A
Date Registered:
19/12/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. A. Blokland c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
1
Name:
The Regents of the University of California
Address:
1111 Franklin Street 12th Floor, OAKLAND, CA 94607-5200, United States of America (US)
2
Name:
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Address:
1124 West Carson Street, 90250-2064, TORRANCE, CA, United States of America (US)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Filing date
Document type
Document Description
Number of pages
File Type
18/12/2023
Outgoing Correspondence
Letter confirmation withdrawal
1
PDF
/6/3/9/0/1/0800210936/docs/300907_14_581711l193.pdf
14/12/2023
Incoming Correspondence Paper
Withdrawal application
1
PDF
/6/3/9/0/1/0800210936/docs/300907_13_incomingcorrespondencepaper20231215011555058.pdf
07/12/2017
Outgoing Correspondence
Outgoing Letter
1
PDF
/6/3/9/0/1/0800210936/docs/300907_12_outgoingcorrespondence20171208040432504.pdf
07/11/2017
Outgoing Correspondence
Confirmation receipt request
1
PDF
/6/3/9/0/1/0800210936/docs/300907_1_172807l174.pdf
03/11/2017
Incoming Correspondence Paper
Accompanying letter incoming document
2
PDF
/6/3/9/0/1/0800210936/docs/300907_0_incomingcorrespondencepaper20171106043300099.pdf
03/11/2017
SPC Documents
Annex SPC
1
PDF
/6/3/9/0/1/0800210936/docs/300907_2_supplprotectioncertificate20200423025646666.pdf
03/11/2017
SPC Documents
Summary of the characteristics of the product
12
PDF
/6/3/9/0/1/0800210936/docs/300907_3_supplprotectioncertificate20171106043259513.pdf
03/11/2017
SPC Documents
Annex SPC
11
PDF
/6/3/9/0/1/0800210936/docs/300907_4_supplprotectioncertificate20200423030719843.pdf
03/11/2017
SPC Documents
Marketing Authorization SPC
2
PDF
/6/3/9/0/1/0800210936/docs/300907_5_supplprotectioncertificate20200423025204832.pdf
03/11/2017
SPC Documents
Annex SPC
42
PDF
/6/3/9/0/1/0800210936/docs/300907_6_supplprotectioncertificate20200423025954395.pdf
03/11/2017
Incoming Correspondence Paper
Accompanying letter incoming document
3
PDF
/6/3/9/0/1/0800210936/docs/300907_7_incomingcorrespondencepaper20200428043200714.pdf
03/11/2017
SPC Documents
Annex SPC
8
PDF
/6/3/9/0/1/0800210936/docs/300907_8_supplprotectioncertificate20200423022806868.pdf
03/11/2017
SPC Documents
Annex SPC
11
PDF
/6/3/9/0/1/0800210936/docs/300907_9_supplprotectioncertificate20200423023254088.pdf
03/11/2017
SPC Documents
Annex SPC
12
PDF
/6/3/9/0/1/0800210936/docs/300907_10_supplprotectioncertificate20200423030558584.pdf
03/11/2017
Application Form
First filed application form
3
PDF
/6/3/9/0/1/0800210936/docs/300907_11_applicationform20171106043258903.pdf